abstract |
The present invention relates, in part, to chimeric proteins comprising the extracellular domain of the colony stimulating factor 1 receptor (CSF1R) and their use in treating diseases, such as immunotherapy for cancer and / or inflammatory diseases. . [Selection diagram] FIG. 1A |